Phase separation of Hippo signalling complexes

EMBO J. 2023 Mar 15;42(6):e112863. doi: 10.15252/embj.2022112863. Epub 2023 Feb 20.

Abstract

The Hippo pathway was originally discovered to control tissue growth in Drosophila and includes the Hippo kinase (Hpo; MST1/2 in mammals), scaffold protein Salvador (Sav; SAV1 in mammals) and the Warts kinase (Wts; LATS1/2 in mammals). The Hpo kinase is activated by binding to Crumbs-Expanded (Crb-Ex) and/or Merlin-Kibra (Mer-Kib) proteins at the apical domain of epithelial cells. Here we show that activation of Hpo also involves the formation of supramolecular complexes with properties of a biomolecular condensate, including concentration dependence and sensitivity to starvation, macromolecular crowding, or 1,6-hexanediol treatment. Overexpressing Ex or Kib induces formation of micron-scale Hpo condensates in the cytoplasm, rather than at the apical membrane. Several Hippo pathway components contain unstructured low-complexity domains and purified Hpo-Sav complexes undergo phase separation in vitro. Formation of Hpo condensates is conserved in human cells. We propose that apical Hpo kinase activation occurs in phase separated "signalosomes" induced by clustering of upstream pathway components.

Keywords: Hippo signalling; condensates; epithelia; mechanobiology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drosophila / metabolism
  • Drosophila Proteins* / metabolism
  • Drosophila melanogaster / metabolism
  • Hippo Signaling Pathway*
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Mammals
  • Neurofibromin 2 / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction / physiology
  • Tumor Suppressor Proteins / metabolism

Substances

  • Tumor Suppressor Proteins
  • Drosophila Proteins
  • Neurofibromin 2
  • hpo protein, Drosophila
  • Protein Serine-Threonine Kinases
  • Intracellular Signaling Peptides and Proteins